These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
659 related articles for article (PubMed ID: 26386386)
1. Exploiting a novel miR-519c-HuR-ABCG2 regulatory pathway to overcome chemoresistance in colorectal cancer. To KK; Leung WW; Ng SS Exp Cell Res; 2015 Nov; 338(2):222-31. PubMed ID: 26386386 [TBL] [Abstract][Full Text] [Related]
2. Posttranscriptional Regulation of Human Antigen R by miR-133b Enhances Docetaxel Cytotoxicity Through the Inhibition of ATP-Binding Cassette Subfamily G Member 2 in Prostate Cancer Cells. Liu H; Song X; Hou J; Zhao Z; Chang J DNA Cell Biol; 2018 Mar; 37(3):210-219. PubMed ID: 29327946 [TBL] [Abstract][Full Text] [Related]
3. Correlation between the promoter methylation status of ATP-binding cassette sub-family G member 2 and drug sensitivity in colorectal cancer cell lines. Moon HH; Kim SH; Ku JL Oncol Rep; 2016 Jan; 35(1):298-306. PubMed ID: 26497773 [TBL] [Abstract][Full Text] [Related]
4. A novel miR-203-DNMT3b-ABCG2 regulatory pathway predisposing colorectal cancer development. To KK; Leung WW; Ng SS Mol Carcinog; 2017 Feb; 56(2):464-477. PubMed ID: 27253631 [TBL] [Abstract][Full Text] [Related]
5. Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2. To KK; Robey RW; Knutsen T; Zhan Z; Ried T; Bates SE Mol Cancer Ther; 2009 Oct; 8(10):2959-68. PubMed ID: 19825807 [TBL] [Abstract][Full Text] [Related]
6. GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer. Feng C; Zhang L; Sun Y; Li X; Zhan L; Lou Y; Wang Y; Liu L; Zhang Y Biomed Pharmacother; 2018 May; 101():945-952. PubMed ID: 29635904 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-149 Increases the Sensitivity of Colorectal Cancer Cells to 5-Fluorouracil by Targeting Forkhead Box Transcription Factor FOXM1. Liu X; Xie T; Mao X; Xue L; Chu X; Chen L Cell Physiol Biochem; 2016; 39(2):617-29. PubMed ID: 27415661 [TBL] [Abstract][Full Text] [Related]
8. The Jun/miR-22/HuR regulatory axis contributes to tumourigenesis in colorectal cancer. Liu Y; Chen X; Cheng R; Yang F; Yu M; Wang C; Cui S; Hong Y; Liang H; Liu M; Zhao C; Ding M; Sun W; Liu Z; Sun F; Zhang C; Zhou Z; Jiang X; Chen X Mol Cancer; 2018 Jan; 17(1):11. PubMed ID: 29351796 [TBL] [Abstract][Full Text] [Related]
9. The C421A (Q141K) polymorphism enhances the 3'-untranslated region (3'-UTR)-dependent regulation of ATP-binding cassette transporter ABCG2. Ripperger A; Benndorf RA Biochem Pharmacol; 2016 Mar; 104():139-47. PubMed ID: 26903388 [TBL] [Abstract][Full Text] [Related]
10. MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2). Jiao X; Zhao L; Ma M; Bai X; He M; Yan Y; Wang Y; Chen Q; Zhao X; Zhou M; Cui Z; Zheng Z; Wang E; Wei M Breast Cancer Res Treat; 2013 Jun; 139(3):717-30. PubMed ID: 23780685 [TBL] [Abstract][Full Text] [Related]
11. Expression of ABCG2 associated with tumor response in metastatic colorectal cancer patients receiving first-line FOLFOX therapy--preliminary evidence. Lin PC; Lin HH; Lin JK; Lin CC; Yang SH; Li AF; Chen WS; Chang SC Int J Biol Markers; 2013 Jun; 28(2):182-6. PubMed ID: 23558935 [TBL] [Abstract][Full Text] [Related]
12. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway. Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179 [TBL] [Abstract][Full Text] [Related]
13. ABCG2 is required for self-renewal and chemoresistance of CD133-positive human colorectal cancer cells. Ma L; Liu T; Jin Y; Wei J; Yang Y; Zhang H Tumour Biol; 2016 Sep; 37(9):12889-12896. PubMed ID: 27449042 [TBL] [Abstract][Full Text] [Related]
14. [Correlation of MDR1 and ABCG2 genetic polymorphisms with the efficacy and adverse events of irinotecan chemotherapy in patients with colorectal cancer]. Sun ZW; Wang XC; Gao J; Li J; Li YY; Dang YZ; Shen L Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jun; 16(6):524-8. PubMed ID: 23801203 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells. Cheng W; Liu T; Wan X; Gao Y; Wang H FEBS J; 2012 Jun; 279(11):2047-59. PubMed ID: 22498306 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of miR-203 sensitizes paclitaxel (Taxol)-resistant colorectal cancer cells through targeting the salt-inducible kinase 2 (SIK2). Liu Y; Gao S; Chen X; Liu M; Mao C; Fang X Tumour Biol; 2016 Sep; 37(9):12231-12239. PubMed ID: 27236538 [TBL] [Abstract][Full Text] [Related]
17. Upregulation of miR-199a/b contributes to cisplatin resistance via Wnt/β-catenin-ABCG2 signaling pathway in ALDHA1 Chen B; Zhang D; Kuai J; Cheng M; Fang X; Li G Tumour Biol; 2017 Jun; 39(6):1010428317715155. PubMed ID: 28639895 [TBL] [Abstract][Full Text] [Related]
18. Elevated microRNA-23a Expression Enhances the Chemoresistance of Colorectal Cancer Cells with Microsatellite Instability to 5-Fluorouracil by Directly Targeting ABCF1. Li X; Li X; Liao D; Wang X; Wu Z; Nie J; Bai M; Fu X; Mei Q; Han W Curr Protein Pept Sci; 2015; 16(4):301-9. PubMed ID: 25929864 [TBL] [Abstract][Full Text] [Related]
19. ABCG2 overexpression in colon cancer cells resistant to SN38 and in irinotecan-treated metastases. Candeil L; Gourdier I; Peyron D; Vezzio N; Copois V; Bibeau F; Orsetti B; Scheffer GL; Ychou M; Khan QA; Pommier Y; Pau B; Martineau P; Del Rio M Int J Cancer; 2004 May; 109(6):848-54. PubMed ID: 15027118 [TBL] [Abstract][Full Text] [Related]
20. [Correlation of chemosensitivity tested using histoculture drug response assay to expression of multidrug resistance genes and proteins in colorectal cancer tissues]. Yuan SQ; Zhou ZW; Liang YJ; Fu LW; Chen G; Qiu HB; Zhang LY Ai Zheng; 2009 Sep; 28(9):932-8. PubMed ID: 19728910 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]